Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bausch & Lomb To Diversify Business in Japan

This article was originally published in PharmAsia News

Executive Summary

U.S. eye care maker Bausch & Lomb plans to diversify from the contact lens business, which accounts for over 90 percent of the company sales in Japan, and venture into cataract surgical machine, pharmaceutical products and other ophthalmic instruments markets, according to Bausch & Lomb Japan's new chairman Mitsuo Hirose.. Bausch & Lomb Japan also plans to increase training to representatives and promote product benefits to ophthalmologists at various seminars. (Click here for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071608

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel